Skip to main content
Top
Published in: La radiologia medica 6/2019

01-06-2019 | Prostate Cancer | ONCOLOGY IMAGING

Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer

Authors: Hamid Abdollahi, Bahram Mofid, Isaac Shiri, Abolfazl Razzaghdoust, Afshin Saadipoor, Arash Mahdavi, Hassan Maleki Galandooz, Seied Rabi Mahdavi

Published in: La radiologia medica | Issue 6/2019

Login to get access

Abstract

Objective

To develop different radiomic models based on the magnetic resonance imaging (MRI) radiomic features and machine learning methods to predict early intensity-modulated radiation therapy (IMRT) response, Gleason scores (GS) and prostate cancer (Pca) stages.

Methods

Thirty-three Pca patients were included. All patients underwent pre- and post-IMRT T2-weighted (T2 W) and apparent diffusing coefficient (ADC) MRI. IMRT response was calculated in terms of changes in the ADC value, and patients were divided as responders and non-responders. A wide range of radiomic features from different feature sets were extracted from all T2 W and ADC images. Univariate radiomic analysis was performed to find highly correlated radiomic features with IMRT response, and a paired t test was used to find significant features between responders and non-responders. To find high predictive radiomic models, tenfold cross-validation as the criterion for feature selection and classification was applied on the pre-, post- and delta IMRT radiomic features, and area under the curve (AUC) of receiver operating characteristics was calculated as model performance value.

Results

Of 33 patients, 15 patients (45%) were found as responders. Univariate analysis showed 20 highly correlated radiomic features with IMRT response (20 ADC and 20 T2). Two and fifteen T2 and ADC radiomic features were found as significant (P-value ≤ 0.05) features between responders and non-responders, respectively. Several cross-combined predictive radiomic models were obtained, and post-T2 radiomic models were found as high predictive models (AUC 0.632) followed by pre-ADC (AUC 0.626) and pre-T2 (AUC 0.61). For GS prediction, T2 W radiomic models were found as more predictive (mean AUC 0.739) rather than ADC models (mean AUC 0.70), while for stage prediction, ADC models had higher prediction performance (mean AUC 0.675).

Conclusions

Radiomic models developed by MR image features and machine learning approaches are noninvasive and easy methods for personalized prostate cancer diagnosis and therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53(5):6–1111CrossRef Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53(5):6–1111CrossRef
2.
go back to reference Kumar V, Bora GS, Kumar R, Jagannathan NR (2018) Multiparametric (mp) MRI of prostate cancer. Prog Nucl Magn Reson 105:23–40CrossRef Kumar V, Bora GS, Kumar R, Jagannathan NR (2018) Multiparametric (mp) MRI of prostate cancer. Prog Nucl Magn Reson 105:23–40CrossRef
3.
go back to reference Wallace T, Torre T, Grob M, Yu J, Avital I, Brücher B et al (2014) Current approaches, challenges and future directions for monitoring treatment response in prostate cancer. J Cancer 5(1):3CrossRefPubMedPubMedCentral Wallace T, Torre T, Grob M, Yu J, Avital I, Brücher B et al (2014) Current approaches, challenges and future directions for monitoring treatment response in prostate cancer. J Cancer 5(1):3CrossRefPubMedPubMedCentral
4.
go back to reference Kelloff GJ, Choyke P, Coffey DS (2009) Challenges in clinical prostate cancer: role of imaging. Am J Roentgenol 192(6):70–1455CrossRef Kelloff GJ, Choyke P, Coffey DS (2009) Challenges in clinical prostate cancer: role of imaging. Am J Roentgenol 192(6):70–1455CrossRef
5.
go back to reference Mazaheri Y, Akin O, Hricak H (2017) Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: a review of current methods and applications. World J Radiol 9(12):416CrossRefPubMedPubMedCentral Mazaheri Y, Akin O, Hricak H (2017) Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: a review of current methods and applications. World J Radiol 9(12):416CrossRefPubMedPubMedCentral
6.
go back to reference Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMedPubMedCentral Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMedPubMedCentral
7.
go back to reference Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Mahdavi SR, Kazemnejad A (2018) Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study. Phys Med 45:7–192CrossRef Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Mahdavi SR, Kazemnejad A (2018) Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study. Phys Med 45:7–192CrossRef
8.
go back to reference Stoyanova R, Takhar M, Tschudi Y, Ford JC, Solórzano G, Erho N et al (2016) Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res 5(4):432CrossRefPubMedPubMedCentral Stoyanova R, Takhar M, Tschudi Y, Ford JC, Solórzano G, Erho N et al (2016) Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res 5(4):432CrossRefPubMedPubMedCentral
9.
go back to reference X-k Niu, Z-f Chen, Chen L, Li J, Peng T, Li X (2018) Clinical application of biparametric MRI texture analysis for detection and evaluation of high-grade prostate cancer in zone-specific regions. Am J Roentgenol 210(3):56–549 X-k Niu, Z-f Chen, Chen L, Li J, Peng T, Li X (2018) Clinical application of biparametric MRI texture analysis for detection and evaluation of high-grade prostate cancer in zone-specific regions. Am J Roentgenol 210(3):56–549
10.
go back to reference Bates A, Miles K (2017) Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer. Eur Radiol 27(12):8–5290CrossRef Bates A, Miles K (2017) Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer. Eur Radiol 27(12):8–5290CrossRef
11.
go back to reference Nketiah G, Elschot M, Kim E, Teruel JR, Scheenen TW, Bathen TF et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27(7):9–3050CrossRef Nketiah G, Elschot M, Kim E, Teruel JR, Scheenen TW, Bathen TF et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27(7):9–3050CrossRef
12.
go back to reference Gnep K, Fargeas A, Gutiérrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD et al (2017) Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45(1):17–103CrossRef Gnep K, Fargeas A, Gutiérrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD et al (2017) Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45(1):17–103CrossRef
13.
go back to reference Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL et al (2016) Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies. Oncotarget 7(33):53362CrossRefPubMedPubMedCentral Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL et al (2016) Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies. Oncotarget 7(33):53362CrossRefPubMedPubMedCentral
14.
go back to reference Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G et al (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360(9329):8–307CrossRef Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G et al (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360(9329):8–307CrossRef
15.
go back to reference Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE et al (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61(13):3–4971 Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE et al (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61(13):3–4971
16.
go back to reference Pearson R, Pieniazek P, Thelwall P, Maxwell R, Plummer R, Frew J (2018) Diffusion-weighted MRI for early response assessment in the treatment of bladder cancer. Clin Oncol 30(3):193CrossRef Pearson R, Pieniazek P, Thelwall P, Maxwell R, Plummer R, Frew J (2018) Diffusion-weighted MRI for early response assessment in the treatment of bladder cancer. Clin Oncol 30(3):193CrossRef
17.
18.
go back to reference Decker G, Mürtz P, Gieseke J, Träber F, Block W, Sprinkart AM et al (2014) Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol 113(1):20–115CrossRef Decker G, Mürtz P, Gieseke J, Träber F, Block W, Sprinkart AM et al (2014) Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol 113(1):20–115CrossRef
19.
go back to reference Desouza N, Reinsberg S, Scurr E, Brewster J, Payne G (2007) Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 80(950):5–90CrossRef Desouza N, Reinsberg S, Scurr E, Brewster J, Payne G (2007) Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 80(950):5–90CrossRef
20.
go back to reference Wolf MB, Edler C, Tichy D, Röthke MC, Schlemmer HP, Herfarth K et al (2017) Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique. J Magn Reson Imaging 46(3):60–850CrossRef Wolf MB, Edler C, Tichy D, Röthke MC, Schlemmer HP, Herfarth K et al (2017) Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique. J Magn Reson Imaging 46(3):60–850CrossRef
22.
go back to reference Parmar C, Grossmann P, Rietveld D, Rietbergen MM, Lambin P, Aerts HJ (2015) Radiomic machine-learning classifiers for prognostic biomarkers of head and neck cancer. Front Oncol 5:272CrossRefPubMedPubMedCentral Parmar C, Grossmann P, Rietveld D, Rietbergen MM, Lambin P, Aerts HJ (2015) Radiomic machine-learning classifiers for prognostic biomarkers of head and neck cancer. Front Oncol 5:272CrossRefPubMedPubMedCentral
23.
go back to reference Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom K et al (2018) Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol 39(2):16–208 Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom K et al (2018) Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol 39(2):16–208
24.
go back to reference Zhang B, He X, Ouyang F, Gu D, Dong Y, Zhang L et al (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:7–21CrossRef Zhang B, He X, Ouyang F, Gu D, Dong Y, Zhang L et al (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:7–21CrossRef
25.
go back to reference Song I, Kim CK, Park BK, Park W (2010) Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. Am J Roentgenol 194(6):W82–W477CrossRef Song I, Kim CK, Park BK, Park W (2010) Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. Am J Roentgenol 194(6):W82–W477CrossRef
26.
go back to reference Wahba MH, Morad MM (2015) The role of diffusion-weighted MRI: in assessment of response to radiotherapy for prostate cancer. Egypt J Radiol Nucl Med 46(1):8–183 Wahba MH, Morad MM (2015) The role of diffusion-weighted MRI: in assessment of response to radiotherapy for prostate cancer. Egypt J Radiol Nucl Med 46(1):8–183
27.
go back to reference Belli P, Costantini M, Ierardi C, Bufi E, Amato D, Mule A et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17(6):9–610CrossRef Belli P, Costantini M, Ierardi C, Bufi E, Amato D, Mule A et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17(6):9–610CrossRef
28.
go back to reference Khalil RF, Abdelhamid AEM, Darwish AMA, Hassan HHM (2017) Diffusion weighted imaging in early prediction of neoadjuvant chemotherapy response in breast cancer. Egypt J Radiol Nucl Med 48(2):35–529 Khalil RF, Abdelhamid AEM, Darwish AMA, Hassan HHM (2017) Diffusion weighted imaging in early prediction of neoadjuvant chemotherapy response in breast cancer. Egypt J Radiol Nucl Med 48(2):35–529
29.
go back to reference Collewet G, Strzelecki M, Mariette F (2004) Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging 22(1):81–91CrossRefPubMed Collewet G, Strzelecki M, Mariette F (2004) Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging 22(1):81–91CrossRefPubMed
30.
go back to reference Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM (2012) Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys 83(4):e5–e551CrossRef Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM (2012) Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys 83(4):e5–e551CrossRef
31.
go back to reference Liu Z, Zhang X-Y, Shi Y-J, Wang L, Zhu H-T, Tang Z-C, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017:clincanres. 1038.2017 Liu Z, Zhang X-Y, Shi Y-J, Wang L, Zhu H-T, Tang Z-C, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017:clincanres. 1038.2017
32.
go back to reference Aerts HJ, Grossmann P, Tan Y, Oxnard GR, Rizvi N, Schwartz LH et al (2016) Defining a radiomic response phenotype: a pilot study using targeted therapy in NSCLC. Sci Rep 6:33860CrossRefPubMedPubMedCentral Aerts HJ, Grossmann P, Tan Y, Oxnard GR, Rizvi N, Schwartz LH et al (2016) Defining a radiomic response phenotype: a pilot study using targeted therapy in NSCLC. Sci Rep 6:33860CrossRefPubMedPubMedCentral
33.
go back to reference Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N et al (2017) Identifying prognostic intratumor heterogeneity using pre-and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol 8(1):127CrossRefPubMedPubMedCentral Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N et al (2017) Identifying prognostic intratumor heterogeneity using pre-and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol 8(1):127CrossRefPubMedPubMedCentral
34.
go back to reference Rao S-X, Lambregts DM, Schnerr RS, Beckers RC, Maas M, Albarello F et al (2016) CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J 4(2):63–257CrossRef Rao S-X, Lambregts DM, Schnerr RS, Beckers RC, Maas M, Albarello F et al (2016) CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J 4(2):63–257CrossRef
35.
go back to reference Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA (2011) Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261(1):71–165CrossRef Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA (2011) Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261(1):71–165CrossRef
36.
go back to reference Cunliffe A, Armato SG III, Castillo R, Pham N, Guerrero T, Al-Hallaq HA (2015) Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. Int J Radiat Oncol Biol Phys 91(5):56–1048CrossRef Cunliffe A, Armato SG III, Castillo R, Pham N, Guerrero T, Al-Hallaq HA (2015) Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. Int J Radiat Oncol Biol Phys 91(5):56–1048CrossRef
37.
go back to reference Fave X, Zhang L, Yang J, Mackin D, Balter P, Gomez D et al (2017) Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep 7(1):588CrossRefPubMedPubMedCentral Fave X, Zhang L, Yang J, Mackin D, Balter P, Gomez D et al (2017) Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep 7(1):588CrossRefPubMedPubMedCentral
38.
go back to reference Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW et al (2016) Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol 119(3):6–480CrossRef Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW et al (2016) Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol 119(3):6–480CrossRef
39.
go back to reference Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD (2014) Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 41(3):033502CrossRefPubMed Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD (2014) Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 41(3):033502CrossRefPubMed
40.
go back to reference Lucia F, Visvikis D, Desseroit M-C, Miranda O, Malhaire J-P, Robin P et al (2018) Prediction of outcome using pretreatment 18 F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 45(5):86–768CrossRef Lucia F, Visvikis D, Desseroit M-C, Miranda O, Malhaire J-P, Robin P et al (2018) Prediction of outcome using pretreatment 18 F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 45(5):86–768CrossRef
41.
go back to reference Hawkins SH, Korecki JN, Balagurunathan Y, Gu Y, Kumar V, Basu S et al (2014) Predicting outcomes of nonsmall cell lung cancer using CT image features. IEEE Access 2:26–1418CrossRef Hawkins SH, Korecki JN, Balagurunathan Y, Gu Y, Kumar V, Basu S et al (2014) Predicting outcomes of nonsmall cell lung cancer using CT image features. IEEE Access 2:26–1418CrossRef
42.
go back to reference Parmar C, Leijenaar RT, Grossmann P, Velazquez ER, Bussink J, Rietveld D et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044CrossRefPubMedPubMedCentral Parmar C, Leijenaar RT, Grossmann P, Velazquez ER, Bussink J, Rietveld D et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044CrossRefPubMedPubMedCentral
43.
go back to reference Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA et al (2015) Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci USA 112(46):E73–E6265CrossRef Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA et al (2015) Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci USA 112(46):E73–E6265CrossRef
44.
go back to reference Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D et al (2015) Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 25(10):50–2840CrossRef Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D et al (2015) Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 25(10):50–2840CrossRef
45.
go back to reference Shiri I, Rahmim A, Ghaffarian P, Geramifar P, Abdollahi H, Bitarafan-Rajabi A (2017) The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies. Eur Radiol 27(11):509–4498CrossRef Shiri I, Rahmim A, Ghaffarian P, Geramifar P, Abdollahi H, Bitarafan-Rajabi A (2017) The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies. Eur Radiol 27(11):509–4498CrossRef
Metadata
Title
Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer
Authors
Hamid Abdollahi
Bahram Mofid
Isaac Shiri
Abolfazl Razzaghdoust
Afshin Saadipoor
Arash Mahdavi
Hassan Maleki Galandooz
Seied Rabi Mahdavi
Publication date
01-06-2019
Publisher
Springer Milan
Published in
La radiologia medica / Issue 6/2019
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-018-0966-4

Other articles of this Issue 6/2019

La radiologia medica 6/2019 Go to the issue